Baxter International (BAX) Accounts Payables (2009 - 2026)
Baxter International's (BAX) quarterly Accounts Payables came in at $1.0 billion in Q2 2026, up 3.92% year-over-year from $995.0 million in Q2 2025, and down 4.79% quarter-over-quarter from $1.1 billion in Q1 2026.
Analysis
Baxter International (BAX) Accounts Payables (2009 - 2026) Analysis & Trends
Baxter International (BAX) has reported Accounts Payables for 18 consecutive years, with $1.0 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Accounts Payables rose 3.92% year-over-year to $1.0 billion in Q2 2026; TTM through Jun 2026 was $1.0 billion, a 3.92% increase from a year earlier, with the FY2025 full-year figure at $999.0 million, up 3.2% from the prior year.
- Accounts Payables was $1.0 billion for Q2 2026 at Baxter International, down from $1.1 billion in the prior quarter.
- Over five years, Accounts Payables peaked at $1.3 billion in Q1 2024 and troughed at $841.0 million in Q3 2024.
- A 5-year average of $1.1 billion and a median of $1.1 billion in 2022 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables gained 27.56% in 2022 and sank 32.5% in 2024, its largest moves.
- Over 5 years, Accounts Payables stood at $1.1 billion in 2022, then decreased by 20.63% to $881.0 million in 2023, then advanced by 9.88% to $968.0 million in 2024, then climbed by 3.2% to $999.0 million in 2025, then increased by 3.5% to $1.0 billion in 2026.
- The last three Accounts Payables figures came in at $1.0 billion (Q2 2026), $1.1 billion (Q1 2026), and $999.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | 6.11 Bn |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | 1.04 Bn |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 252.70 Mn |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 1.03 Bn |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | 297.48 Mn |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | 14.15 Mn |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | 3.18 Mn |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | 6.70 Mn |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | 1.36 Mn |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | 1,177.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.03 Bn |
| Mar 31, 2026 | 1.09 Bn |
| Dec 31, 2025 | 999.00 Mn |
| Sep 30, 2025 | 953.00 Mn |
| Jun 30, 2025 | 995.00 Mn |
| Mar 31, 2025 | 963.00 Mn |
| Dec 31, 2024 | 968.00 Mn |
| Sep 30, 2024 | 841.00 Mn |
| Jun 30, 2024 | 1.25 Bn |
| Mar 31, 2024 | 1.33 Bn |
| Dec 31, 2023 | 881.00 Mn |
| Sep 30, 2023 | 1.25 Bn |
| Jun 30, 2023 | 1.24 Bn |
| Mar 31, 2023 | 1.29 Bn |
| Dec 31, 2022 | 1.11 Bn |
| Sep 30, 2022 | 1.23 Bn |
| Jun 30, 2022 | 1.28 Bn |
| Mar 31, 2022 | 1.22 Bn |
| Dec 31, 2021 | 1.25 Bn |
| Sep 30, 2021 | 999.00 Mn |